Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
about
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@en
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@nl
type
label
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@en
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@nl
prefLabel
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@en
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@nl
P2093
P2860
P50
P1476
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
@en
P2093
Angelika Caputo
Giovanni Marotta
J Michael Ryan
Judit Sovago
Marie-Emmanuelle Riviere
Martin Farlow
R Paul Maguire
P2860
P356
10.1016/J.TRCI.2016.12.003
P407
P577
2016-12-23T00:00:00Z